Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three ...
Satyanarayana Chava of Laurus Labs stated that global pharma firms prioritise sustainability, scale, and compliance over cost, making capability-building essential for Indian CDMOs. Neeraj Sharma of ...
The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench. With this consolidation, the ...
Hyderabad: The National Company Law Tribunal has sanctioned the scheme of amalgamation between contract development and ...
Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as ...
4d
The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.
3d
Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...
Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...
Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...
As much as $135 million in value will be unlocked as stock of five companies eligible for trading as their shareholder ...
In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback